Vanguard Group »

Fulcrum Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 2.5M 6.75
2023-09-30 $12M 2.6M 4.44
2023-06-30 $8.7M 2.6M 3.30
2023-03-31 $8.2M 2.9M 2.85
2022-12-31 $15M 2.1M 7.28
2022-06-30 $7.5M 1.5M 4.90
2022-03-31 $36M 1.5M 23.65
2021-09-30 $35M 1.3M 28.21
2021-06-30 $9.5M 907k 10.46
2021-03-31 $9.9M 843k 11.79
2020-12-31 $7.7M 661k 11.71
2020-09-30 $4.8M 607k 7.93
2020-06-30 $7.8M 425k 18.29
2020-03-31 $1.4M 116k 11.94
2019-12-31 $1.2M 74k 16.63
2019-09-30 $105k 16k 6.59